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Recent studies of obesity have provided new insights
into the mechanisms underlying insulin resistance
and metabolic dysregulation. Numerous efforts
have been made to identify key regulators of
obesity-linked adipose tissue inflammation and
insulin resistance. We found that angiopoietin-like
protein 2 (Angptl2) was secreted by adipose tissue
and that its circulating level was closely related to
adiposity, systemic insulin resistance, and inflamma-
tion in both mice and humans. Angptl2 activated
an inflammatory cascade in endothelial cells via
integrin signaling and induced chemotaxis of mono-
cytes/macrophages. Constitutive Angptl2 activation
in vivo induced inflammation of the vasculature char-
acterized by abundant attachment of leukocytes to
the vessel walls and increased permeability. Angptl2
deletion ameliorated adipose tissue inflammation
andsystemic insulin resistance indiet-inducedobese
mice. Conversely, Angptl2 overexpression in adipose
tissuecaused local inflammationandsystemic insulin
resistance in nonobese mice. Thus, Angptl2 is a key178 Cell Metabolism 10, 178–188, September 2, 2009 ª2009 Elsevieadipocyte-derived inflammatory mediator that links
obesity to systemic insulin resistance.
INTRODUCTION
Obesity is a pandemic medical and social problem that is asso-
ciated with several adverse health outcomes, including type 2
diabetes, hypertension, dyslipidemia, cardiovascular disease,
and cancer (Eckel et al., 2005; Mokdad et al., 2003), all of which
result in increased mortality. A major metabolic manifestation of
obesity is systemic insulin resistance. Recently, the concept has
emerged that chronic low-grade activation of proinflammatory
pathways in adipose tissue directly promotes systemic insulin
resistance (Apovian et al., 2008; Neels and Olefsky, 2006;
Schenk et al., 2008). Adipocytes and macrophages could be
a source of several proinflammatory cytokines that activate
inflammatory pathways in resident and infiltrating cells within
adipose tissue in a paracrine or autocrine fashion (Kanda et al.,
2006; Weisberg et al., 2006). However, the molecular mecha-
nisms underlying inflammation of adipose tissue in obesity
have not fully clarified.
Fibrinogen promotes leukocyte adhesion and cytokine secre-
tion at sites of inflammation through integrin-dependent inflam-
matory pathways (Herrick et al., 1999; Mosesson, 2005).r Inc.
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Figure 1. Angptl2 Is Secreted by Adipose
Tissue
(A) Angptl2 mRNA expression in various tissues of
mice fed normal chow (n = 4). WAT, white adipose
tissue; sub, subcutaneous; peri, perirenal; mes,
mesenteric; BAT, brown adipose tissue; S.
Muscle, skeletal muscle.
(B–D) Angptl2 mRNA expression in 3T3-L1 cells
during adipocyte differentiation (n = 3) (B), in differ-
entiated 3T3-L1 cells incubated under hypoxic
conditions (1% O2, 24 hr, n = 3) (C), and in cells
treated with palmitate (200 mM, 24 hr, n = 4) (D).
(E) Angptl2 protein levels in culture medium of
pre- (Pre) or postdifferentiated (Adipo) 3T3-L1 cells
with or without palmitate treatment (200 mM,
24 hr, n = 4).
(F) Angptl2 mRNA expression in the mesenteric
adipose tissue of obese mice fed a high-fat diet
for the indicated periods starting at 8 weeks of
age (n = 4).
(G) Representative western blot and quantitative
evaluation of serum Angptl2 protein in mice fed
a normal diet (ND) or a high-fat diet (HFD) for
a period of 8 weeks (n = 4). CBB-stained albumin
is as control bands for protein loading. Data are
the mean ± SEM, *p < 0.05 and **p < 0.01
compared with controls.Fibrinogen-binding integrins are abundantly expressed by
monocytes/macrophages and endothelial cells, and fibrinogen
must undergo oligomerization or polymerization to display its
activity. The presence of extravascular fibrinogen at sites of
inflammation has been documented by pathologists for decades
(Dvorak et al., 1985). These findings prompted us to ask whether
an oligomeric protein derived from adipose tissue and containing
a fibrinogen-like sequence might play a pathological role in
inflammatory changes of adipose tissue associated with obesity.
Recently, we and others identified seven angiopoietin-like
proteins (Angptls), which possess a coiled-coil domain at the
N terminus for oligomerization and a C-terminal fibrinogen-like
domain (Kim et al., 1999; Kubota et al., 2005a; Oike et al.,
2004). Angptls are structurally similar to Tie-2 receptor ligands
(angiopoietins), but Angptls do not bind to either Tie2 or the
homologous Tie1 protein, indicating that their role differs from
that of angiopoietins.
Here we show that angiopoietin-like protein 2 (Angptl2) is
primarily secreted by adipose tissue and that its expression is
increased by obesity and obesity-related pathological condi-
tions, including hypoxia and endoplasmic reticulum (ER) stress.
We found that increased circulating Angptl2 levels were closely
related to adiposity, systemic insulin resistance, and inflamma-
tion in both mice and humans. Angptl2 acted on endothelial cells
and monocytes/macrophages via integrin signaling, resulting in
the promotion of inflammation. Constitutive activation of Angptl2
in mouse skin tissue induced chronic inflammation, including
inflammatory changes of the vasculature characterized by abun-
dant attachment of leukocytes to the vessel walls and increasedCell Mpermeability. Deletion of Angptl2 led to reduced inflammation in
adipose tissue and ameliorated systemic insulin resistance in
mice with dietary obesity. Conversely, persistent overexpression
of Angptl2 in adipose tissue caused local inflammation and
systemic insulin resistance in nonobese mice. These findings
establish Angptl2 as a key adipocyte-derived inflammatory
mediator linking obesity to systemic insulin resistance and
identify it as a new molecular target that could be used to
improve the diagnosis and treatment of obesity and related
metabolic diseases.
RESULTS
Angptl2 Expression in White Adipose Tissue Is
Increased by Obesity and Obesity-Related Stress
Angptl2 mRNA was widely expressed in various organs of mice,
but its level was particularly elevated in visceral white adipose
tissues (Figure 1A). Differentiated 3T3-L1 adipocytes expressed
Angptl2 mRNA (Figure 1B), and its expression was increased
by hypoxia (Figure 1C), which occurs in obese adipose tissue
(Hosogai et al., 2007; Nishimura et al., 2008; Schenk et al.,
2008; Ye, 2009). We found significantly increased ER stress in
adipocytes from obese mice compared with cells from nonob-
ese mice (see Figure S1 available online). Serum levels of long-
chain saturated fatty acids (LCSFAs) are elevated in obesity,
and LCSFAs promote ER stress in adipocytes (Schenk et al.,
2008). Our in vitro study of cultured 3T3-L1 cells revealed that
ER stress was induced in adipocytes after treatment with palmi-
tate, one of the LCSFA, or thapsigargin, an ER stress inducer. Asetabolism 10, 178–188, September 2, 2009 ª2009 Elsevier Inc. 179
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Figure 2. Circulating Angptl2 Is Correlated with Adiposity, Insulin Resistance, and Inflammation in Humans
(A) Immunohistochemical staining for Angptl2 in human adipose tissue. Scale bar, 100 mm.
(B) Correlation of the serum Angptl2 level with the body mass index or serum insulin, glucose, and CRP levels in healthy volunteers (n = 98).
(C) Serum Angptl2 levels in healthy volunteers (Healthy, n = 98) and in patients with type 2 diabetes (DM, n = 89) or coronary artery disease (CAD, n = 109). Hori-
zontal bars represent the 10%–90% percentile range, and boxes indicate the 25%–75% percentile range. The horizontal line in each box corresponds to the
median.
(D) Correlation of the serum Angptl2 level with the visceral fat area, HOMA-R index, M value, and CRP level in diabetic patients.
(E and F) Changes of the plasma Angptl2 level in obese diabetic male patients after pioglitazone treatment (n = 27). Plasma Angptl2 levels (mean ± SEM) before
and after treatment (E). Correlation of the change (%) of the plasma Angptl2 level with the change (%) of the visceral fat area, subcutaneous fat area, HOMA-R
index, and CRP level. Correlation coefficient (R) and probability (P) values are shown (F). *p < 0.05 and **p < 0.01 compared with controls.a result, both the cellular Angptl2 mRNA level and its protein
concentration in the culture mediumwere significantly increased
(Figures 1D and 1E, Figure S2, and data not shown). Angptl2
mRNA in mesenteric white adipose tissue and serum Angptl2
protein levels were increased in obese mice fed a high-fat diet
(Figures 1F and 1G), suggesting that Angptl2 is a bioactive
adipocyte-derived factor that has a role in obesity and related
metabolic diseases.
Circulating Angptl2 Level Is Correlated with Adiposity,
Systemic Insulin Resistance, and Inflammation
in Humans
Immunohistochemical analysis revealed that Angptl2 was ex-
pressed by the adipocytes of human adipose tissue (Figure 2A).
We analyzed the circulating levels of Angptl2 in various human
subjects by using an enzyme-linked immunosorbent assay
(ELISA). In healthy normal-weight volunteers aged from 20 to
59 years, the serum Angptl2 concentration ranged from 1.36 to
4.98 ng/ml, and the distribution was normal after log transforma-
tion (Figure S3A). Plasma levels were comparable and strongly
correlated with the corresponding serum levels (Figure S3B).
There was no significant difference of serum Angptl2 concentra-180 Cell Metabolism 10, 178–188, September 2, 2009 ª2009 Elsevietion between genders (data not shown). Angptl2 level showed
a positive correlation with body mass index, serum insulin
level, and serum C-reactive protein (CRP) level. In contrast, the
level of Angptl4, which has already been identified as an adipo-
cyte-derived Angptl, showed no correlation with these factors
in normal-weight healthy subjects (Figure 2B and Figure S4).
An increase of the body mass index, serum insulin level, and
CRP level is associated with the development of type 2 diabetes
and atherosclerosis (Eckel et al., 2005; Mokdad et al., 2003).
Indeed, serum Angptl2 was also significantly increased in
patients with type 2 diabetes or coronary artery disease (Fig-
ure 2C). In 935 consecutive persons aged 27–84 years who
underwent a medical checkup and gave informed consent for
measurement of serum Angptl2 at the Japanese Red Cross
Kumamoto Health Care Center, the Angptl2 level was positively
correlated with the body mass index, abdominal circumference,
and serumCRP level (Figure S5). In patients with type 2 diabetes,
Angptl2 was positively correlated with the visceral fat area,
homeostasis model assessment of insulin resistance (HOMA-R)
index (Matthews et al., 1985), and serum CRP level, but not with
the subcutaneous fat area. Angptl2 level was inversely corre-
lated with the insulin sensitivity index (M value), as assessedr Inc.
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1979) (Figure 2D).
These observations led us to ask whether improvement of
systemic insulin resistance or inflammation would influence
the circulating level of Angptl2. We observed a significant
decrease of the plasma Angptl2 level in 27 obese diabetic men
following treatment with pioglitazone at 30 mg/day for 3 months
(Figure 2E). The percent decrease of the plasma Angptl2 level
was correlated with the percent decrease of the visceral fat
area, HOMA-R index, and serum CRP level (Figure 2F). These
results suggested that visceral fat was likely to be the main
source of circulating Angptl2, the concentration of which was
significantly correlated with systemic insulin resistance and
inflammation.
Angptl2 Activates Migration and Inflammatory Changes
of Endothelial Cells and Monocytes/Macrophages via
Integrins
Since the vasculature hasan important role in tissue inflammation
(Jackson et al., 1997), we examined the effect of Angptl2 on
endothelial cells. First, we found a dose-dependent increase of
cell adhesion when human umbilical vein endothelial cells
(HUVECs) and human arterial endothelial cells (HAECs), which
express several integrins on their surfaces, were plated on
Angptl2-coated plates (Figures 3A and S6). We next analyzed
cell adhesion in the presenceof a series of function-blocking anti-
bodies for specific integrins. A neutralizing antibody for integrin
a5b1 inhibited endothelial cell adhesion to Angptl2-coated
plates, as did RGDpeptide, which blocks RGD-dependent integ-
rins (Figure 3B), suggesting that Angptl2-induced endothelial cell
adhesionwas an a5b1-dependent process, although the involve-
ment of untested integrins could not be excluded. Integrin a5b1
activates NF-kB in endothelial cells (Klein et al., 2002). Consis-
tently, there was increased translocation of NF-kB to the nucleus
and degradation of IkB in HUVECs stimulated with recombinant
human Angptl2 protein (Figures 3C and 3D).
Angptl2 also promoted the migration of HUVECs and HAECs
through a microchemotaxis membrane (Figure 3E). Time-lapse
imaging of HUVECs or HAECs cultures revealed that protrusion
of lamellipodia and membrane ruffling were rapidly induced
following the addition of Angptl2 (Movies S1 and S2). Since
Rac1, a small Rho-GTPase, plays a pivotal role in the protrusion
of lamellipodia, membrane ruffling, and cell migration (Bar-Sagi
and Hall, 2000; Fryer and Field, 2005), we investigated whether
Rac1 was activated in HAECs and HUVECs by performing
a pull-down assay. Activation of Rac1 was detected in both
Angptl2-stimulated HUVECs and HAECs (Figure 3F). In viable
Angptl2-stimulated HUVECs, a single-molecule probe was
used to determine Rac1 activity, showing that it was diffusely
activated at the plasma membrane, with this activation being
followed by protrusion of lamellipodia and membrane ruffling
(Figure 3G and Movie S3). Moreover, Angptl2 no longer stimu-
lated the protrusion of lamellipodia and membrane ruffling in
HUVECs transfected with a dominant-negative Rac1 mutant
expressing red fluorescent protein (RacN17-IRES-RFP) (Fig-
ure 3H andMovie S4). These findings suggest that Angptl2-stim-
ulated lamellipodia formation and membrane ruffling in endothe-
lial cells were both mediated by activation of Rac1. Next, we
investigated whether Angptl2 could induce in vivo chemotaxisCell Mof endothelial cells in a mouse cornea assay. Implanted pellets
containing Angptl2 markedly induced neovascularization in the
mouse cornea, whereas pellets containing PBS alone did not
(Figure 3I). Monocytes/macrophages express several integrin
receptors that are responsible for adhesion, migration, and
extravasation into the peripheral tissues (Friedl and Weigelin,
2008; Rose et al., 2007). We found that the THP-1 human mono-
cytic cell line expressed integrins a4, b1, b2, anda5b1 (Figure 3J).
THP-1 cells adhered to Angptl2-coated plates in a dose-depen-
dent manner (Figure 3K). FACS analysis revealed that Angptl2
bound to THP-1; this binding was completely inhibited by
neutralizing antibodies for integrins a4 or b2 and was partially
blocked by antibodies for integrin a5b1 or b1 (Figure 3L). Angptl2
also promoted transmigration by THP-1 cells and primary human
monocytes (Figure 3M and Figure S7).
Constitutive Angptl2 Activation Induces Local
Inflammation in Mouse Skin Tissue
To further investigate the role of Angptl2 in the inflammatory
process, we generated transgenic mice expressing Angptl2
driven by the keratinocyte-specific promoter K14 (K14-Angptl2)
and therefore constitutively expressing Angptl2 in the epidermis
(Figures S8A and S8B). The ears, snouts, and eyelids of K14-
Angptl2 mice were redder than those of controls. The tails of
K14-Angptl2 mice were not only reddish but also swollen and
showed loss at the tips (Figure 4A), indicating local inflammation.
Lectin staining showed an increase of adherent leukocytes,
a common feature of inflammatory vasculature (McDonald,
1994), in enlarged vessels of the skin tissue specimens from
K14-Angptl2 mice (Figure 4B), while there was no difference of
vessel length between the genotypes (Figure S8C). The vessels
of K14-Angptl2 mice were significantly more permeable than
the vessels of wild-type controls after inflammation was induced
by topical application of mustard oil, a potent proinflammatory
agent (Figure 4C). As expected, even before mustard oil applica-
tion, lumens of CD31+LYVE-1+ lymphatics were enlarged in
the skin of K14-Angptl2 mice, while such changes were not
observed in controls (Figure 4D), suggesting that increased
drainage via lymphatics was compensating for the excessive
leakiness of Angptl2-stimulated vessels in the dermis. These
findings indicate that Angptl2 induces inflammatory vascular
remodeling rather than angiogenesis.
Reduction of Adiposity and Obesity-Related Adipose
Tissue Inflammation in Angptl2/ Mice
Next, we investigated the pathophysiological role of Angptl2 by
generating Angptl2 knockout (Angptl2/) mice (Figure S9).
Angptl2/mice were born alive following Mendelian inheritance
and appeared to be grossly normal. Interestingly, when fed
normal chow, Angptl2/ mice weighed slightly less (Fig-
ure S10A) and had a lower body fat mass estimated by
computed tomography (CT) (Figures S10B and S10C) than
heterozygotes or wild-type mice fed the same normal diet,
although there was no significant difference of daily food intake
or energy expenditure between the groups (Figures S10D and
S10E). In addition, Angptl2/ mice showed slightly, but signifi-
cant, better glucose tolerance and insulin sensitivity (Figures
S10F and S10G). Next, we fed 8-week-old mice a high-fat
diet containing 32% (wt/wt) fat to stimulate weight gain. Afteretabolism 10, 178–188, September 2, 2009 ª2009 Elsevier Inc. 181
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Figure 3. Angptl2 Activates Endothelial Cells and Monocytes
(A) Adhesion of HUVECs or HAECs to culture dishes coated with various concentrations of recombinant human Angptl2 (n = 3).
(B) HUVECs or HAECs were preincubated with or without 25 mg/ml of blocking antibodies (anti-a5b1, anti-avb3, or anti-avb5) or RGD or RGE peptides (300 mM),
and cell adhesion was assessed (n = 3). As a negative control, cell adhesion was assayed in the presence of 10 mM EDTA, which inhibits integrin binding.
(C) Nuclear translocation of NF-kB subunit p65 in HUVECs at 2 hr after Angptl2 stimulation. Nuclei were counterstained with 40,60-diamidino-2-phenylindole
(DAPI). Scale bar, 20 mm.
(D) Representative western blots of IkB and Hsc70 protein (internal control) in HUVECs at the indicated times after Angptl2 stimulation.
(E) Migration of HUVECs or HAECs in response to Angptl2 (n = 4).
(F) HUVECs or HAECs were cultured with Angptl2 for 30 min and then subjected to the pull-down assay using GST-PAK-CRIB followed by western blotting with
anti-Rac1 antibody. Representative images are shown.
(G) HUVECs expressing Raichu-Rac1 (a probe for active Rac1) at the indicated times (min) after Angptl2 stimulation. Arrows indicate nascent and retracting
lamellipodia. Ratio ranges are shown on the right.
(H) HUVECs that were either untransfected or transfected with RacN17 (shown in red in the left panel and by red stars in the center and right panels) and
stimulated with Angptl2 at time 0 and 15 min. Angptl2-stimulated membrane ruffling is observed in HUVECs without RacN17 (arrows).
(I) Macroscopic appearance of neovascularization in the mouse cornea. Pellets containing vehicle or Angptl2 (0.5 mg) were implanted into micropockets cut in the
corneal stroma.
(J) Integrin expression by THP-1 cells. Typical profiles obtained by FACS analysis with the indicated anti-integrin antibodies (black line traces) or isotype-matched
control IgG (filled gray traces).
(K) Adhesion of THP-1 cells to culture dishes coated with various concentrations of Angptl2 (n = 3).
(L) Inhibition of Angptl2 binding to THP-1 cells by integrin-neutralizing antibodies. THP-1 cells were preincubated with (red line traces) or without (blue line traces)
the indicated anti-integrin neutralizing antibodies, and then incubated with FLAG-tagged Angptl2 followed by detection with FITC-conjugated anti-FLAG
antibody. Negative controls (filled gray traces) had omission of Angptl2.
(M) Migration of THP-1 cells in response to Angptl2 (n = 7–9). Data are the mean ± SD, *p < 0.05 and **p < 0.01 compared with controls.8 weeks of high-fat diet feeding, Angptl2/ mice had a body
weight 12% lower than that of wild-type mice (Figure 5A). The
visceral and subcutaneous fat mass and total body fat
percentage were moderately decreased in Angptl2/ mice
compared to wild-type mice (Figures 5B and 5C). Considerable
accumulation of fat was seen in the liver and skeletal muscle of
wild-type mice, whereas these changes were mild in Angptl2/182 Cell Metabolism 10, 178–188, September 2, 2009 ª2009 Elseviemice (Figures 5D and 5E). Although there were no obvious differ-
ences of food intake or energy expenditure between the two
groups, the respiratory quotient was significantly lower in the
Angptl2/ group (Figures S11A–S11C).
We next examined the expression of mRNAs for inflammatory
cytokines (IL-6 and TNF-a), a chemokine (MCP-1), various
macrophage markers (F4/80, CD68, CCR2, Mgl1, and Mgl2),r Inc.
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Scale bar, 100 mm.and insulin-sensitizing adipocytokines (adiponectin and leptin)
in the adipose tissue of mice fed a high-fat diet. As shown in
Figure 5F, adiponectin expression was increased, while TNF-a
and general (F4/80, CD68) and inflammatory (CCR2) macro-
phage markers were all decreased in the adipose tissue of
Angptl2/ mice. However, the expression of residential macro-
phage markers (Mgl1 and Mgl2) remained unchanged. Further-
more, expression of F4/80 mRNA was positively correlated
with the adipose tissue weight in controls, indicating that
adiposity was significantly correlated with macrophage infiltra-
tion into adipose tissue. In contrast, there was no significant
correlation between adipose tissue weight and macrophage
infiltration in Angptl2/ mice (Figure 5G), suggesting that this
decrease of macrophage infiltration may be independent of
reduced adiposity in Angptl2/mice. Furthermore, immunohis-
tochemistry using the macrophage marker Mac2 revealed accu-
mulation of Mac2-positive macrophages in crown-like structures
within the adipose tissue of wild-type mice, while fewer Mac2-
positive cells were observed in the adipose tissue of Angptl2/
mice (Figure 5H). The high-fat diet caused impaired glucose
tolerance and insulin resistance in controls, whereas Angptl2/
mice showed better glucose tolerance and insulin sensitivity
based on the results of intraperitoneal glucose and insulin toler-
ance tests (GTT and ITT, respectively) (Figures 5I and 5J). To
explore which organ(s) contributed to the improved insulin sensi-
tivity in Angptl2/ mice, we next performed western blottingCell Meanalysis of the insulin signaling pathway. Tyrosine phosphoryla-
tion of insulin receptor b and serine phosphorylation of Akt
after insulin injection were significantly increased in both the
liver and skeletal muscle of Angptl2/ mice compared with
wild-type mice (Figure 5K). To confirm these results, we per-
formed hyperinsulinemic-euglycemic clamp experiments. Both
glucose infusion rate and whole-body glucose disposal rate
were significantly increased in Angptl2/ mice, while clamp
endogenous glucose production was significantly reduced. In
addition, the percent decrease in endogenous glucose produc-
tion from basal to clamp states was significantly higher in
Angptl2/mice than in wild-type mice (Figure 5L). These results
indicated that insulin sensitivity was improved in both the skel-
etal muscle and liver of Angptl2/ mice fed a high-fat diet.
Angptl2 Promotes Local Inflammation in Adipose Tissue
and Systemic Insulin Resistance
Finally, we determined whether sustained overexpression of
Angptl2 in adipose tissue promoted systemic insulin resistance
by generating transgenic mice that overexpressed Angptl2 in
adipose tissue under the control of aP2, an adipose tissue-
specific promoter (aP2-Angptl2) (Figure S12A). Based on the
level of Angptl2 expression, we considered that line 5 was the
most acceptable model for examining the pathological role of
increased Angptl2 expression in obese mice (Figure S12B), so
we performed subsequent analyses using line 5 and wild-typetabolism 10, 178–188, September 2, 2009 ª2009 Elsevier Inc. 183
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Figure 5. Deletion of Angptl2 Reduces Adipose Tissue Inflammation and Systemic Insulin Resistance in Dietary Obese Mice
Analyses of Angptl2/ and wild-type mice fed a HFD for 8 weeks (A–L).
(A) Body weight of each genotype (n = 8–16 per group) at the indicated times (weeks) after initiation of a HFD.
(B and C) Representative CT findings (B) and quantitative comparison of the visceral (V) and subcutaneous (S) fat volume and total percent body fat (C) in
Angptl2/ mice and wild-type mice (n = 5–7 per group).
(D) HE-stained liver sections from Angptl2/ and wild-type mice. Scale bar, 100 mm.
(E) Triglyceride (TG) content of liver and skeletal muscle from Angptl2/ mice and wild-type mice (n = 6 per group).
(F) Quantitative RT-PCR of mRNAs encoding adipocytokines andmacrophagemarkers in epididymal adipose tissue from Angptl2/ and wild-typemice (n = 11–
12 per group).
(G) Correlation between F4/80 mRNA expression and epididymal adipose tissue weight in Angptl2/mice and wild-type mice (n = 11–12 per group). Correlation
coefficient (R) and probability (P) values are shown.
(H) Immunohistochemistry of adipose tissue using the macrophage marker MAC2 and adipocyte marker perillipin. Representative photographs and quantitative
comparisons of MAC2-positive cells (n = 6 per group) are shown. Scale bar, 100 mm.
(I and J) Glucose (I) and insulin (J) tolerance tests in Angptl2/ mice and wild-type mice (n = 5 and n = 10 per group, respectively).
(K) Insulin signaling in the liver and skeletal muscle of Angptl2/ (KO) and wild-type (WT) mice. Representative western blots and quantitative data for the total
and phosphorylated forms of insulin receptor b subunit (IRb) and Akt are shown (n = 4 per group).
(L) Glucose infusion rate (GIR), glucose disposal rate, endogenous glucose production (EGP) during the basal and clamped states, and percent change in EGP
between the states in Angptl2/ (KO) and wild-type (WT) mice (n = 5–7 per group). Data are mean ± SEM, *p < 0.05 and **p < 0.01 compared with controls.littermates as controls. There was no difference of weight gain
between aP2-Angptl2 mice and control wild-type mice fed
a normal chow diet (Figure 6A). However, immunohistochemistry
using Mac2 revealed accumulation of macrophages in crown-
like structures within the adipose tissue of aP2-Angptl2 mice,
whereas fewer Mac2-positive cells were observed in wild-type
mice (Figure 6B). RT-PCR analysis revealed that inflammatory184 Cell Metabolism 10, 178–188, September 2, 2009 ª2009 Elseviecytokines (IL-6, TNF-a, and IL-1b) and general (CD68) and
inflammatory (CCR2) macrophage markers were increased in
the adipose tissue of aP2-Angptl2 mice, while adiponectin and
leptin were unchanged (Figure 6C). Lectin staining showed an
increase of adherent leukocytes in vessels within the adipose
tissue of aP2-Angptl2 mice, while few leukocytes were detected
in the vessels of wild-type mice (Figure 6D). There was nor Inc.
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Figure 6. Angptl2 in Adipose Tissue Induces Local Inflammation and Systemic Insulin Resistance
Analyses of aP2-Angptl2 and wild-type mice at 16 weeks of age (B–H).
(A) Body weight of aP2-Angptl2 and wild-type mice (n = 14–16 per group) at the indicated ages (months).
(B) Immunohistochemistry of adipose tissue using the macrophage marker MAC2 and adipocyte marker perillipin. Representative photograghs and quantitative
comparison of MAC2-positive cells are shown (n = 6 per group). Scale bar, 50 mm.
(C) Quantitative RT-PCR of mRNAs encoding adipocytokines and macrophage markers in epididymal adipose tissue from aP2-Angptl2 mice and wild-type mice
(n = 6 per group).
(D) Blood vessels in epidydimal adipose tissue from aP2-Angptl2 and wild-type mice. Arrows indicate adherent leukocytes on the walls of enlarged vessels in
aP2-Angptl2 mice. Scale bar, 25 mm.
(E and F) Glucose (E) and insulin (F) tolerance tests in aP2-Angptl2 mice and wild-type mice (n = 10–12 per group).
(G) Insulin signaling in the liver and skeletal muscle of aP2-Angptl2 (TG) and wild-type (WT) mice. Representative western blots and quantitative data for the total
and phosphorylated forms of insulin receptor b subunit (IRb) and Akt are shown (n = 4 per group).
(H) Glucose infusion rate (GIR), glucose disposal rate, endogenous glucose production (EGP) during the basal and clamped states, and percent change in EGP
between the states in aP2-Angptl2 (TG) and wild-type (WT) mice (n = 7 per group). Data are mean ± SEM, *p < 0.05 and **p < 0.01 compared with controls.difference of blood vessel density between aP2-Angptl2 mice
and control mice (Figure S12C). aP2-Angptl2 mice showed
glucose intolerance and insulin resistance in the GTT and ITT,
respectively (Figures 6E and 6F). Insulin signaling was dimin-
ished in both liver and skeletal muscle of aP2-Angptl2 mice
compared with wild-type mice (Figure 6G). The hyperinsuline-
mic-euglycemic clamp tests also revealed insulin resistance in
both skeletal muscle and liver of aP2-Angptl2 mice, since the
glucose infusion rate, whole-body glucose disposal rate, and
percent change of endogenous glucose production between
basal and clamp states were reduced in aP2-Angptl2 mice
comparedwith wild-typemice, while hepatic glucose production
during the clamp period was increased in aP2-Angptl2 mice
compared with control mice (Figure 6H). These results indicated
the presence of insulin resistance in both the skeletal muscle and
liver of nonobese aP2-Angptl2 mice.Cell MDISCUSSION
We demonstrated that Angptl2, a member of the Angptl family, is
a key mediator of chronic adipose tissue inflammation and
obesity-related systemic insulin resistance.
Here we showed that Angptl2 is an adipocyte-derived inflam-
matory mediator, with increased expression at both the mRNA
and protein levels in obesity. Hypoxia and ER stress, which are
enhanced in obese adipose tissue (Hosogai et al., 2007; Nishi-
mura et al., 2008; Schenk et al., 2008; Ye, 2009), both increased
Angptl2 expression or secretion in adipocytes. Various changes
of themicroenvironment observed in the adipose tissue of obese
animals, such as inflammation and hypoxia, could also promote
ER stress (Schenk et al., 2008). Therefore, Angptl2 production
by adipocyte should be increased by hypoxia and ER stress in
obesity.etabolism 10, 178–188, September 2, 2009 ª2009 Elsevier Inc. 185
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Angptl2 Causes Adipose Tissue InflammationIt is noteworthy that the circulating Angptl2 level was positively
correlated with obesity-related metabolic changes. The differ-
ence of circulating Angptl2 protein levels between Angptl2 Tg
mice and wild-type mice was only 1.5-fold, but tissue Angptl2
levels showed a 3- to 5-fold difference (data not shown). There-
fore, the modest difference of circulating Angptl2 levels in
humans may reflect a larger alteration of adipose tissue Angptl2
expression, which could promote inflammation of adipose
tissue, resulting in systemic insulin resistance. We also do not
exclude the possibility that there is a direct inhibitory effect of
circulating Angptl2 on insulin sensitivity in other peripheral
tissues, such as skeletal muscle or the liver, because glucose
clamp studies and western blotting analysis of insulin signaling
revealed that both skeletal muscle and liver were target organs
for Angptl2-related insulin resistance inmice. Other Angptl family
molecules function in an endocrine manner to regulate lipids,
glucose, and energy metabolism (Hato et al., 2008; Oike et al.,
2005a, 2005b), so further studies are needed to clarify whether
Angptl2 might also act in an endocrine manner.
Angptl2 contains an N-terminal coiled-coil domain and a
C-terminal fibrinogen-like domain. The coiled-coil domain is
required for oligomerization, which is necessary for its maximum
activity, while the fibrinogen-like domain shares high homology
with the analogous domain of fibrinogen. Fibrinogen acts as
a ligand of the receptors for integrins such as avb3, a5b1, and
aMb2 (Herrick et al., 1999; Mosesson, 2005), which are heterodi-
meric transmembrane glycoproteins that mediate cell-extracel-
lular matrix and cell-cell adhesion (Hynes, 2002). Angptl3 was
reported to promote angiogenesis through integrin avb3 (Came-
nisch et al., 2002). In this study, we found that Angptl2 acted on
endothelial cells through integrin a5b1 and influenced mono-
cytes/macrophages through integrins a4 or b2. Several reports
have indicated that integrin a5b1 signaling activates Rac1 in
endothelial cells (Dormond et al., 2001; Mettouchi et al., 2001),
in agreement with our finding that Angptl2 promotes Rac1 acti-
vation in endothelial cells. We also found that Angptl2 induced
the chemotaxis of endothelial cells by in vitro time-lapse imaging
analysis and an in vivo mouse cornea neovascularization assay.
In contrast, constitutive overexpression of Angptl2 in mouse skin
or adipose tissue induced pathological vascular inflammation
but did not increase vascularization or ameliorate hypoxia in
the adipose tissue of mice with dietary obesity (Figure S12D).
The cornea is an avascular tissue and thus is isolated from circu-
lating soluble bioactive mediators, whereas various angiogen-
esis-related factors exist in highly vascular tissues such as the
skin and adipose tissue. Taken together, these findings indicate
that Angptl2 may function differently in different tissues, but it
promotes vascular inflammation rather than angiogenesis, at
least in adipose tissue that develops in obese mice.
Potentially relevant to these findings, we observed that
Angptl2 stimulated the nuclear translocation of NF-kB and
degradation of IkB in cultured vascular endothelial cells, findings
consistent with a previous report that integrin a5b1 signaling
activates NF-kB-dependent expression of genes that are impor-
tant for inflammation (Klein et al., 2002). There have been several
other reports that Rac1 activates NF-kB (Perona et al., 1997;
Sulciner et al., 1996), which is also consistent with our findings.
An important aspect of inflammation is the recruitment of
immune cells to affected tissues (Luster et al., 2005). This186 Cell Metabolism 10, 178–188, September 2, 2009 ª2009 Elsevieprocess requires adhesion of the immune cells to endothelial
cells, allowing extravasation into the interstitium, followed by
adhesion of immune cells to the extracellular matrix that enables
migration toward the site of inflammation. In this regard, Angptl2
not only activated NF-kB in endothelial cells, which could induce
expression of adhesion molecules (such as ICAM, VCAM, and
selectin) and thus facilitate adhesion of immune cells to endothe-
lial cells, but also promoted themigration of monocytes. Immune
cells express integrins a4 or b2, as well as a5b1, which mediate
cell adhesion, migration, activation, and production of proinflam-
matory cytokines through activation of NF-kB (Hynes, 2002;
Rose et al., 2007; Roman et al., 2004; Graves and Roman,
1996), suggesting that Angptl2 may activate monocytes via
such integrins. It remains to be clarified whether only Angptl2
among the Angptl family shows a stimulatory effect on adipose
tissue inflammation, because some other members of this family
bind to integrins (Camenisch et al., 2002), and Angptl4 is also
abundantly expressed in adipose tissue. The skin tissue of
K14-Angptl4 mice showed no inflammatory changes (Ito et al.,
2003), unlike that of K14-Angptl2 mice. Moreover, there was
no correlation between the serum Angptl4 concentration and
Angptl2-related metabolic factors. These findings suggest that
the effects of Angptl4 on endothelial cells and/or immune cells
are different from those of Angptl2.
In this study, we demonstrated that Angptl2 deletion not only
ameliorated inflammation in adipose tissue but also improved
systemic insulin resistance in mice with dietary obesity, although
it did not completely normalize their insulin sensitivity to the
level seen in mice fed a normal chow diet (Figure S11I). The
restoration of insulin sensitivity related to Angptl2 deletion may
be attributable to the difference of body fat accumulation
between the two genotypes. Since adipose tissue volume was
not correlated with macrophage infiltration in Angptl2/ mice,
some mechanism other than the difference of adiposity may
also have contributed to reducing adipose tissue inflammation
in Angptl2/ mice. Actually, constitutive Angptl2 overexpres-
sion in adipose tissue induced both local inflammation and
systemic insulin resistance in nonobese mice. Since adipose
tissue inflammation can be a cause of systemic insulin resistance
via the secretion of several inflammatory factors (Apovian et al.,
2008; Neels and Olefsky, 2006; Schenk et al., 2008), it is sug-
gested that Angptl2 probably influenced systemic insulin sensi-
tivity by exacerbating adipose tissue inflammation (Figure S13).
Although a reduction of adipose tissue inflammation could well
be the main reason for improvement of insulin sensitivity in
Angptl2/ mice, some other possible mechanisms remain.
Adiponectin can potentially increase insulin sensitivity, and the
adiponectin level is usually decreased in obesity (Kadowaki
and Yamauchi, 2005). However, there was no difference of circu-
lating adiponecin levels between Angptl2/ and control mice
(Figure S11H).On the other hand,Angptl2/micehad a reduced
triglyceride content in both skeletal muscle and liver, which could
improve insulin sensitivity in these two organs (Schenk et al.,
2008).
Angptl2/ mice showed reduced body fat and tissue triglyc-
eride accumulation when fed a high-fat diet, although there was
no obvious difference of daily food intake and energy expendi-
ture estimated from the O2 consumption rate. Interestingly, the
respiratory quotient of Angptl2/ mice was significantly lowerr Inc.
Cell Metabolism
Angptl2 Causes Adipose Tissue Inflammationthan that of wild-type mice, suggesting that Angptl2/ mice
were more likely to use lipids than carbohydrates for oxidation
to create energy. There was also a trend of increased expression
of lipid oxidation genes in the skeletal muscle of Angptl2/mice
and increased UCP1 expression in brown adipose tissue
(Figures S11D and S11F), whichmay account for the lower respi-
ratory quotient, decreased triglyceride content of skeletal
muscle, and decrease of whole-body fat in Angptl2/ mice.
On the other hand, the hepatic expression of lipogenic genes
(SREBP-1c, FAS, and SCD1) was significantly decreased in
Angptl2/ mice (Figure S11G), which explains the decreased
triglyceride content in the liver of these mice, although further
studies will be needed to clarify the molecular mechanisms
involved.
In summary, this study provided evidence that Angptl2 plays
a key role in inflammation of adipose tissue via inflammatory
vascular remodeling and recruitment of macrophages into
adipose tissue. These findings suggest that Angptl2 may be an
important part of the mechanism underlying adipose tissue
inflammation that is involved in the pathogenesis of systemic
insulin resistance related to obesity. The present findings should
also lead to new treatment strategies for obesity and related
insulin resistance.
EXPERIMENTAL PROCEDURES
Materials and additional methods are available in the Supplemental Experi-
mental Procedures.
Animal Study
All experimental protocols were approved by the Ethics Review Committee for
Animal Experimentation of Kumamoto University. Only male mice were used
for the experiments. For the metabolic analyses, mice at 8 weeks of age
were fed either a normal diet (CE-2; CLEA, Japan) or a high-fat diet (HFD-32;
CLEA) for a period of 8 weeks. During the analyses, mice continued to feed
on the same diet.
Human Studies
White adipose tissue samples were obtained from the intact adipose tissue
surrounding the tumor resected from a patient with pancreatic carcinoma.
Samples were fixed in 4% paraformaldehyde for 24 hr and embedded in
paraffin. Sections 5 mm thick were cut and stained with an anti-Angptl2 poly-
clonal antibody (#383). Nuclei were counterstained with hematoxylin. A total
of 98 volunteers working at Kumamoto University were enrolled in the study
as the healthy group (persons with obesity [body mass index > 30] or diabetes
were excluded). Blood samples were collected, and the plasma glucose,
insulin, and CRP levels were measured. A total of 89 patients with type 2 dia-
betes were enrolled as the DM group. Their abdominal fat content was evalu-
ated by magnetic resonance imaging. The HOMA-R index was calculated as
the product of fasting plasma insulin (mU/ml) and fasting plasma glucose
(mg/dl) divided by 405 (Matthews et al., 1985). The euglycemic-hyperinsuline-
mic clamp test was carried out according to a protocol described elsewhere
(DeFronzo et al., 1979). A total of 109 patients with coronary artery disease
(diagnosed by coronary angiography) were enrolled as the CAD group, and
blood samples were collected. Twenty-seven obese diabetic men who had
not previously received any antidiabetic agents, antihypertensive agents, or
lipid-lowering drugs were treated with pioglitazone at a dose of 30 mg/day
for 3 months. Before and after treatment, the abdominal fat content was eval-
uated by CT scanning, and fasting blood samples were collected to measure
the levels of glucose, insulin, and CRP. Blood samples were also collected
from 935 consecutive volunteers aged 27–84 years, who underwent medical
checkups at the Japanese Red Cross Kumamoto Health Care Center. Serum
or plasma levels of Angptl2 and Angptl4 were measured by ELISA. This study
was approved by the Ethics Committees of Kumamoto University (healthy andCell MCAD groups), Kobe University (DM group), Ryukyu University (pioglitazone
study), and the Japanese Red Cross Kumamoto Health Care Center. Written
informed consent was obtained from each subject.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, 13 figures, one table, and four movies and can be found
with this article online at http://www.cell.com/cell-metabolism/supplemental/
S1550-4131(09)00232-0.
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